-
Interview: Markus Schümmelfeder, CIO, Boehringer Ingelheim
16 Apr 2025 14:37 GMT
… ways to help biopharmaceutical giant Boehringer Ingelheim exploit digital and data. He … the business community”
Markus Schümmelfeder, Boehringer Ingelheim
Another key area of research …
-
Features : Where People Come First - Boehringer Ingelheim Malaysia's Award-Winning Employee-Centric Culture
16 Apr 2025 04:56 GMT
… Lives for Generations’.
“Boehringer Ingelheim’s culture of emphasising internal … THROUGH LEADERSHIP PROGRAMME
For Boehringer Ingelheim Malaysia’s district sales … Marketing, Boehringer Ingelheim Malaysia, Kelvin Ha
Tan said similarly, Boehringer Ingelheim’s …
-
Boehringer Ingelheim, Cue Biopharma partner to develop next─generation treatment for autoimmune and inflammatory diseases
16 Apr 2025 03:39 GMT
… and respiratory diseases research at Boehringer Ingelheim. “By leveraging Cue Biopharma … collaboration and license agreement with Boehringer Ingelheim,” said Daniel Passeri, chief … payments on net sales.
Boehringer Ingelheim is a biopharmaceutical company …
-
Boehringer Ingelheim and Cue Biopharma agree to advance CUE-501 for autoimmune diseases
15 Apr 2025 18:50 GMT
Immune
Boehringer Ingelheim Pharma GmbH & Co KG …
-
Boehringer Ingelheim Boosts I&I Portfolio With $357M in Biobucks for Cue
15 Apr 2025 13:50 GMT
… develop and commercialize CUE-501, Boehringer Ingelheim is pledging up to $345 … Monday’s release.
Carine Boustany, Boehringer Ingelheim’s global head of Immunology … year.
Additionally, in September 2024, Boehringer Ingelheim reported that its drug candidate …
-
Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases
15 Apr 2025 06:00 GMT
… royalty payments on net sales.
Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company active … business.
Media Contacts
Boehringer Ingelheim:
Dr. Reinhard Malin
Boehringer Ingelheim Corporate Center GmbH
Innovation …
-
Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases
14 Apr 2025 21:00 GMT
… and license agreement with Boehringer Ingelheim,” said Daniel Passeri, … on net sales. Boehringer Ingelheim
Boehringer Ingelheim is a biopharmaceutical company … Media Contacts Boehringer Ingelheim:
Dr. Reinhard Malin
Boehringer Ingelheim Corporate Center GmbH …
-
How U.S. Medicare Prices Compare to Other Rich Nations
16 Apr 2025 17:07 GMT
…
Eliquis
🇺🇸 Bristol-Myers Squibb
Jardiance
🇩🇪 Boehringer Ingelheim
🇺🇸 Eli Lilly
Xarelto
🇺🇸 Janssen (Johnson …
-
Recommendations for Improving Discharge-Related Care Following a COPD Exacerbation: An Expert Panel Consensus with Emphasis on Low- and Middle-Income Countries
16 Apr 2025 13:31 GMT
… honoraria from AstraZeneca, GlaxoSmithKline, and Boehringer Ingelheim for lectures given at meetings …
-
Does Thrombolysis Affect Outcomes in Tandem Lesion Stroke?
16 Apr 2025 12:19 GMT
… -analysis received support from Stryker, Boehringer Ingelheim, and the Amsterdam University Medical …
About
© 1995-2025